v3.26.1
Interim Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities    
Net income $ 533,465 $ 333,785
Adjustments to reconcile net income to net cash flows    
Depreciation and amortization 159,457 134,240
Amortization of debt transaction costs 15,954 14,022
Foreign currency (gain) loss on debt (15,656) 73,696
Share based compensation expense 37,890 36,365
Interest income (50,320) (39,897)
Interest expense 143,087 156,660
Other 5,212 (1)
Changes in working capital:    
Increase in deferred revenue 435,702 330,076
Changes in other liabilities and assets (147,759) 18,164
Increase in inventories (14,576) (601)
Changes in deferred tax assets and liabilities 6,240 3,116
Changes in other non-current assets and other non-current liabilities 30,657 3,184
Income taxes paid (8,054) (4,243)
Net cash flow from operating activities 1,131,299 1,058,566
Cash flows from investing activities    
Investments in property, plant and equipment and intangible assets (1,266,788) (814,382)
Capital contribution to associated company 0 (6,500)
Loan to related party (36,882) 0
Proceeds from repayment of related party loan 31,251 0
Interest received 50,235 31,115
Net cash flow used in investing activities (1,222,184) (789,767)
Cash flows from financing activities    
Repayment of long-term debt (317,731) (372,886)
Proceeds from long-term debt 800,046 430,507
Transaction costs incurred for long-term debt (45,179) (41,912)
Proceeds from issuance of ordinary shares from equity plans 10,087 9,600
Principal payments for lease liabilities (13,344) (17,451)
Interest payments for lease liabilities (9,083) (9,546)
Interest paid (159,994) (159,126)
Other (559) (867)
Net cash flow from (used in) financing activities 264,243 (161,681)
Change in cash and cash equivalents 173,358 107,118
Effect of exchange rate changes on cash and cash equivalents 2,784 8,223
Net increase in cash and cash equivalents 176,142 115,341
Cash and cash equivalents at January 1 3,803,944 2,489,672
Cash and cash equivalents at June 30 3,985,421 $ 2,605,013
Amendments to IFRS 9 and IFRS 7    
Cash flows from financing activities    
Cash and cash equivalents at January 1 $ 3,809,279